Stents: Vascular - Boston Scientific
WEBThe Innova Stent System is designed to provide a precise, predictable experience for vascular interventionalists. It is purpose-built for the treatment of SFA lesions and expertly engineered for smooth deployment and accurate placement.
Vascular Surgery Products - Boston Scientific
WEBThe Innova Stent System is designed to provide a precise, predictable experience for vascular interventionalists. It is purpose-built for the treatment of SFA lesions and expertly engineered for smooth deployment and accurate placement.
Eluvia™ Drug-Eluting Vascular Stent System - Boston Scientific
WEBHear what physicians have to say about the challenges of treating the SFA and how drug-eluting vascular stents may help improve patient outcomes. Eluvia provides consistent, durable outcomes in challenging SFA disease and features a …
Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System …
WEBOct 6, 2021 · The Eluvia stent, which features sustained release of the lowest dose of paclitaxel of any peripheral drug-eluting device, re-opens blocked arteries and restores blood flow while utilizing a drug...
Eluvia™ Drug-eluting Vascular Stent System ... - Boston Scientific
WEBSep 28, 2015 · The Eluvia Stent System is the first stent specifically designed for deployment in the superficial femoral artery (SFA) that utilizes the anti-restenotic drug paclitaxel in conjunction with a polymer.
Boston Scientific Receives FDA Approval for the Ranger™ Drug …
WEBNov 2, 2020 · Boston Scientific provides first portfolio comprised of drug-eluting stent and drug-coated balloon for the treatment of patients with peripheral artery disease.
Boston Scientific Announces FDA Approval of Innova™ Vascular …
WEBAug 19, 2015 · MARLBOROUGH, Mass., Boston Scientific Corporation has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an advanced treatment option for patients with narrowing or blockages in the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Epic™ Vascular Self-Expanding Stent System - Boston Scientific
WEBVascular Self-Expanding Stent System. Ideal for the Iliac: The Epic Stent is a self-expanding Nitinol stent designed to sustain vessel patency, while providing enhanced visibility and accuracy during placement.
New Drug-Eluting Stents | Circulation: Cardiovascular Interventions
WEBAug 1, 2010 · After the acquisition of Labcoat, Boston Scientific has recently developed the JACTAX DES system (Boston Scientific Corp, Natick, Mass) comprising the market approved stainless steel (316 L) Liberté premounted stent (Boston Scientific), the antiproliferative agent, paclitaxel, in a reduced dose coupled with …
FDA approves Boston Scientific’s new drug-coated balloon for …
WEBMar 1, 2024 · Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent Drug-Coated Balloon (DCB) for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease.